#Inluriyo #Imlunestrant #BreastCancer #Oncology #ESR1Mutation #FDAApproval #CancerResearch #TargetedTherapy #PrecisionMedicine #MetastaticBreastCancer #EliLilly #OncoPharma To view or add a comment, sign in Development Strategy for 71 Integrin-Enhancing Therapy in DMD In July 2025, the TREAT-NMD Advisory Committee for Therapeutics (TACT) reviewed our development strategy for a novel oral small molecule designed to enhance expression of 71 integrin in muscle
Not so long ago, buccal fat removal and its signature suck-on-a-straw look was going viral
A recent study has shown that the absence of EMCN disrupts endothelial homeostasis
Common combinations functional medicine providers use include Tesamorelin or CJC-1295 for fat-loss leverage, MOTS-c for mitochondrial support, BPC-157 for recovery between training sessions, and 5-Amino-1MQ for NNMT-driven recomposition
Many patients see reductions in LDL cholesterol and improvements in their overall lipid profile
2G), in agreement with genetic studies in murine models 31
